Praxis Precision Medicines I logo

Praxis Precision Medicines I Share Price (NASDAQ: PRAX)

$45.26

β–²

0.46

(1.03%)

Last updated on

Check the interactive Praxis Precision Medicines I Stock chart to analyse performance

Praxis Precision Medicines I stock performance

as on August 22, 2025 at 12:36 AM IST

  • Today's Low:$44.36
    Today's High:$45.27

    Day's Volatility :2.01%

  • 52 Weeks Low:$26.70
    52 Weeks High:$91.83

    52 Weeks Volatility :70.92%

Praxis Precision Medicines I Stock Returns

PeriodPraxis Precision Medicines ISector (Health Care)Index (Russel 2000)
3 Months
18.04%
4.5%
0.0%
6 Months
-43.15%
-6.1%
0.0%
1 Year
-15.38%
-11.1%
0.0%
3 Years
-19.82%
3.4%
-9.6%

Praxis Precision Medicines I Key Stats

Check Praxis Precision Medicines I key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$45.25
Open
$45.0
Today's High
$45.89
Today's Low
$44.5
Market Capitalization
$942.7M
Today's Volume
$284.5K
52 Week High
$91.83
52 Week Low
$26.7
Revenue TTM
$7.8M
EBITDA
$-271.4M
Earnings Per Share (EPS)
$-12.4
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-60.98%

Stock Returns calculator for Praxis Precision Medicines I Stock including INR - Dollar returns

The Praxis Precision Medicines I stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

β‚Ή1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Praxis Precision Medicines I investment value today

Current value as on today

β‚Ή88,620

Returns

β‚Ή11,380

(-11.38%)

Returns from Praxis Precision Medicines I Stock

β‚Ή15,307 (-15.31%)

Dollar Returns*

β‚Ή3,927 (+3.93%)

Indian investors sentiment towards Praxis Precision Medicines I Stock

105%

Period: Jul 21, 2025 to Aug 20, 2025. Change in 30 Days versus previous period

Search interest for Praxis Precision Medicines I Stock from India on INDmoney has increased by 105% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Praxis Precision Medicines I

  • Name

    Holdings %

  • HHG PLC

    12.04%

  • Cormorant Asset Management, LLC

    8.29%

  • Adage Capital Partners Gp LLC

    8.28%

  • T. Rowe Price Associates, Inc.

    7.00%

  • BlackRock Inc

    6.73%

  • Vanguard Group Inc

    5.78%

Analyst Recommendation on Praxis Precision Medicines I Stock

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Praxis Precision Medicines I(by analysts ranked 0 to 5 stars)

Praxis Precision Medicines I Share Price Target

What analysts predicted

Upside of 120.21%

Target:

$99.67

Current:

$45.26

Praxis Precision Medicines I share price target is $99.67, a slight Upside of 120.21% compared to current price of $45.26 as per analysts' prediction.

Praxis Precision Medicines I Stock Insights

  • Price Movement

    In the last 7 days, PRAX stock has moved down by -5.2%
  • PRAX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 79.5%
  • PRAX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.1% return, outperforming this stock by 131.3%
  • Price to Sales

    ForPRAX every $1 of sales, investors are willing to pay $118.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.1 for every $1 of sales.

Praxis Precision Medicines I Technicals Summary

Sell

Neutral

Buy

Praxis Precision Medicines I is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Praxis Precision Medicines I Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Praxis Precision Medicines I logo
-18.39%
-43.15%
-15.38%
-19.82%
-89.16%
Regeneron Pharmaceuticals, Inc. logo
5.39%
-15.07%
-50.13%
-3.42%
-0.61%
Beone Medicines Ltd logo
4.61%
26.63%
56.19%
78.75%
30.26%
Vertex Pharmaceuticals Incorporated logo
-16.11%
-17.89%
-18.87%
34.22%
47.47%
Alnylam Pharmaceuticals, Inc. logo
40.82%
82.49%
64.08%
110.21%
247.67%

About Praxis Precision Medicines I

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.
Organization
Praxis Precision Medicines I
Employees
116
CEO
Mr. Marcio Silva De'Souza M.B.A.
Industry
Health Technology

Key Management of Praxis Precision Medicines I

NameTitle
Mr. Marcio Silva De'Souza M.B.A.
President, CEO & Director
Mr. Timothy Edwin Kelly
CFO & Treasurer
Mr. Alex Nemiroff J.D.
General Counsel & Secretary
Dr. Steven Petrou B.Sc. (Hons.), Ph.D.
Co-Founder & Chief Scientific Officer
Lauren Mastrocola
VP of Finance & Principal Accounting Officer
Dr. Karl Hansen Ph.D.
Chief Technical Operations Officer
Mr. Alex Kane
VP of Investor Relations & Corporate Communications
Ms. Kelly McCue
Chief People Officer
Ms. Alyssa J. S. Wyant
Chief Regulatory & Quality Officer
Ms. Megan T. Sniecinski
Chief Business Officer

Important FAQs about investing in PRAX Stock from India :

What is Praxis Precision Medicines I share price today?

Praxis Precision Medicines I share price today is $45.26 as on at the close of the market. Praxis Precision Medicines I share today touched a day high of $45.27 and a low of $44.36.

What is the 52 week high and 52 week low for Praxis Precision Medicines I share?

Praxis Precision Medicines I share touched a 52 week high of $91.83 and a 52 week low of $26.70. Praxis Precision Medicines I stock price today i.e. is closed at $45.26, lower by 50.71% versus the 52 week high.

How to invest in Praxis Precision Medicines I Stock (PRAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Praxis Precision Medicines I on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Praxis Precision Medicines I Shares that will get you 0.0331 shares as per Praxis Precision Medicines I share price of $45.26 per share as on August 22, 2025 at 12:36 AM IST.

What is the minimum amount required to buy Praxis Precision Medicines I Stock (PRAX) from India?

Indian investors can start investing in Praxis Precision Medicines I (PRAX) shares with as little as β‚Ή87.2 or $1 (as of August 21, 2025) using the INDmoney app.
For example: If you want to invest $10 or β‚Ή872.00 in Praxis Precision Medicines I stock (as per the Rupee-Dollar exchange rate as on August 21, 2025). Based on Praxis Precision Medicines I share’s latest price of $45.26 as on August 22, 2025 at 12:36 AM IST, you will get 0.2209 shares of Praxis Precision Medicines I. Learn more about fractional shares .

What are the returns that Praxis Precision Medicines I has given to Indian investors in the last 5 years?

Praxis Precision Medicines I stock has given -89.16% share price returns and 17.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?